Na-Acetyl-L-lysine methyl ester hydrochloride, 95.0%, 250mg

2-Methyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine, 95+%, 100mg

1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-4-carbonitrile, 97.0%, 250mg

{2-[(4-methyl-1-piperidinyl)sulfonyl]ethyl}amine oxalate, 95.0%, 1g

Ethyl 2-acetoxycyclopropanecarboxylate, 95.0%, 5g

N-(2,4-difluorophenyl)-3-oxobutanamide, 95.0%, 5g

N2-(4-Fluorobenzyl)-5-nitropyridine-2,6-diamine, 95.0%, 25g

7-Chloro-3-methylthieno[2,3-c]pyridine, 98%, 1g

3-chloro-N-cyclopropylpyrazin-2-amine, 95.0%, 500mg

(2R,4S)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 96%, 50mg

(2-Chloro-5-methylphenyl)methanamine, 98+%, 250mg

Vigreux column with fused-on vacuum shell, 300 mm, 29/32, 1 Piece

2-(2-Naphthyl)-2-propanol, 97.0%, 500mg